Free Trial

Corporate Debt Issuance Roundup

PIPELINE

$16.4B Priced Monday, led by Eli Lilly, Caterpillar and BoA, over half of the total high grade issuance estimated for the week. Docket looking bare at the moment with issuers sidelined ahead of PPI data - should accelerate in the near term as the latest earning cycle winds down.

  • Date $MM Issuer (Priced *, Launch #)
  • 8/12 $5B *Eli Lilly $750M 3Y +35, $1B 5Y +50, $1.25B 10Y +70, $1.25B 30Y +88, $750M 40Y +100
  • 8/12 $2.5B *Caterpillar $750M 2Y +47, $500M 2Y SOFR+69, $650M 3Y +58, $600M 5Y +68
  • 8/12 $2.5B *Bank of America 11NC10 +152
  • 8/12 $1.75B *NatWest $500M 4.25NC3.25 SOFR+130, $1.25B 6NC5 +122
  • 8/12 $1.2B *CDW $600M +5Y +137.5, $600M 10Y +168
  • 8/12 $800M *CenterPoint Energy $400M 30.5NC5.25 7%, $400M 30.5NC10.25 6.85%
  • 8/12 $650M *Equifax +5Y +105
  • 8/12 $500M *Principle Life 3Y +80
  • 8/12 $500M *Arrow Electronics 5Y +143
  • 8/12 $500M *EnLink Midstream 10Y +180
  • 8/12 $500M *O'Reilly Automotive 10Y +113
  • 8/12 $1.5B JetBlue 7NC3 7%a investor calls

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.